Past & Present Research Opportunities

Since 2008, nearly 8,000 men and women have participated in over a dozen RMA clinical trials aimed at improving patient outcomes.

Past & Present Research Opportunities

Since 2008, nearly 8,000 men and women have participated in over a dozen RMA clinical trials aimed at improving patient outcomes.


Our Research Program

Current Research Opportunities

Please note that eligibility cannot be assessed or guaranteed based on the below information until a new patent visit and diagnostic work up has been completed.

Endocrine Disruptor Study

  • < 42yo proceeding with IVF and preimplantation genetic screening (PGS)
  • Single embryo transfer
  • Nulliparous
  • BMI ≥ 18.5-30 kg/m2
  • Severe male factor
  • Endometrial insufficiency
  • Abnormal karyotype
  • Thrombophilia
  • Uncorrected systemic/endocrine diseases

No direct benefit to participants outside of potentially helping future couples seeking treatment.

Microbiome Study

Women less than 45yo and male partners less than 60yo proceeding with an IVF cycle with preimplantation genetic screening (PGS) and single embryo transfer.

  • >1 prior failed IVF cycle
  • Third party reproduction
  • Cryopreserved sperm
  • Mullerian anomalies
  • Submucosal fibroids
  • Communicating hydrosalpinx

No direct benefit to participants outside of potentially helping future couples seeking treatment.

SOLAIRE

  • Anti-Mullerian hormone (AMH) level < or = 1.1ng/mL, tested within the previous year
  • Total basal antral follicle count less than or equal to eight
  • Male partner with >100,000 total motile spermatozoa per ejaculate (donor sperm acceptable)

Patients who are randomized to the comprehensive chromosome screening (CCS) group will receive CCS free of charge and will also not be charged for additional blood work or embryonic genetic analysis.

LO2 (Phase 2)

  • You are between the age of 18 and 40
  • You would like your embryos to undergo comprehensive chromosome screening free of charge
  • Planning for a single embryo transfer of the best quality embryo
  • You have had no more than one failed IVF cycle at RMANJ

Complimentary comprehensive chromosome screening on the embryo(s) generated through the study cycle.

Past Research Opportunities

LO2 (2016)

CAREs Trial (2015)

ENMOTION (2015)

The Nature Cycle Study (2013)

neXgen (2013)

SuMMIT (2013)

B.E.S.T. Trial (2013)

CCS Efficacy Study (2011)

Impact of Embryo Biopsy Study (2009)

Request Your First Appointment

Our team will be in contact with you shortly after
Back to toparrow_drop_up